MedTrace Logo

Study to Evaluate the Influence of Tegoprazan on the Pharmacokinetics of Proguanil in Healthy Volunteers

NCT04568772 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 19

Last updated 2021-09-27

No results posted yet for this study

Summary

The aim of this study is to evaluate the influence of tegoprazan on the pharmacokinetics of proguanil in healthy volunteers.

Conditions

  • Gastroesophageal Reflux Disease

Interventions

DRUG

Atovaquone / Proguanil 250/100 mg

Atovaquone / Proguanil 250/100 mg tablet

DRUG

Tegoprazan 50 mg

Tegoprazan 50 mg tablet

DRUG

Esomeprazole 40 mg

Esomeprazole 40 mg tablet

DRUG

Vonoprazan 20 mg

Vonoprazan 20 mg tablet

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • SeungHwan Lee, MD, PhD · Seoul National University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-25
Primary Completion
2021-07-08
Completion
2021-08-03

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04568772 on ClinicalTrials.gov